Investasi Saham PepGen anjlok 44% akibat hasil uji klinis yang mengecewakan – Investing.com By admin 1 month ago , Post Content .[#item_full_content] . Sumber : Berita Saham GlobalContinue ReadingPrevious Carlyle Group rencanakan dana pertahanan di tengah belanja militer – Investing.comNext Asing Net Sell Rp686,13 Miliar, BBRI dan BBCA Paling Banyak Dijual – Warta EkonomiLeave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment *Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ
